GenSight Biologics S.A. (GSGTF)
OTCMKTS · Delayed Price · Currency is USD
0.2400
-0.0800 (-25.00%)
At close: Dec 31, 2024

GenSight Biologics Market Cap

GenSight Biologics has a market cap or net worth of $24.96 million as of August 1, 2025. Its market cap has decreased by -29.20% in one year.

Market Cap
24.96M
Enterprise Value
44.19M
Revenue
2.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.24

Market Cap Chart

Since July 13, 2016, GenSight Biologics's market cap has decreased from 279.96M to 24.96M, a decrease of -91.08%. That is a compound annual growth rate of -23.42%.

History

DateMarket Cap% Change
Aug 1, 202524.96M-27.05%
Dec 31, 202434.22M20.63%
Dec 29, 202328.37M-82.90%
Dec 30, 2022165.86M-42.89%
Dec 31, 2021290.43M-21.99%
Dec 31, 2020372.30M308.86%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Jul 13, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition